– USA, MA – Alegeus, the market leader in consumer funding technology, today announced the appointment of Greg Deavens to its Board of Directors, effective immediately.
“We are so excited to add Greg’s expertise as a member of our Board of Directors,” said CEO, Leif O’Leary. “His exceptional experiences in the healthcare and benefits markets – especially as a senior leader of a premiere health insurance plan – will offer unique insights to help us sharpen our innovation strategies, continue to become a more client-centric organization, and unlock the full potential of the customers we serve. He also brings a proven track record and true passion for diversity and inclusion – which is an important focus for Alegeus.”
In his role, Greg Deavens will provide strategic counsel to support continuous innovation to enhance the Alegeus value proposition, extend its leadership position in the market, and provide deep market and customer insights to fuel relentless focus on being a client-first organization.
About Gregory E. Deavens
Greg Deavens is president and CEO for Independence Health Group, parent of Independence Blue Cross, one of the nation’s leading health insurers. He joined Independence in 2017 as EVP, CFO, and treasurer. In this capacity, he led the company’s financial functions as well as its Actuarial, Underwriting, Corporate Development, and Enterprise Risk Management organizations. Before joining Independence, Deavens held senior financial roles at MassMutual, NY Life, CIGNA, and GE Capital.
Deavens has extensive experience in board service roles, including his current roles as chairman of the Board of Directors of Hartford HealthCare and board member for Blue Cross Blue Shield Association (which represents Blue plans covering 106 million Americans), America’s Health Insurance Plans, Quartet Health, and formerly the Executive Leadership Council, among others.
“I am passionate about making sure people have access to high quality, equitable care — that is really at the core of the work that I do in my professional life,” said Greg Deavens. “Alegeus is doing important work to ensure that people can afford the care that they need now and in the future. I am excited to work alongside Leif and the leadership team as we continue to further accelerate innovation and transform healthcare experiences by leveraging the power of consumer funding.”
Greg Deavens is a member of the National Association of Corporate Directors, the American Institute of Certified Public Accountants, and the Missouri Society of Certified Public Accountants. He holds a Bachelor of Science degree in accounting from Florida A&M University.
About Alegeus
Alegeus is the market leader in consumer funding solutions, delivering the industry’s leading white-label platform that transforms how consumers save and pay for healthcare. Our next-generation technology simplifies the administration of healthcare benefit accounts (including FSAs, HSAs, HRAs, wellness incentives, dependent care, and commuter accounts) and COBRA, using data-driven insights to guide consumers to the best coverage, cash, and care strategies. More than 350 Alegeus clients – including health insurance plans and third-party administrators – leverage our deep expertise and proven technology to administer benefit accounts for more than 30 million members and to process more than $9.1 billion in consumer healthcare payments annually. As part of the Vista Equity Partners portfolio of companies, Alegeus benefits from increased capital for strategic investments, access to exceptional toolkits, best practices and resources for success, and strong cultural and value alignment focused on talent development and growth. The company is headquartered in Waltham, MA with operations in Orlando, FL, and Milwaukee, WI.
For more information: https://www.alegeus.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
